Cytogel Pharma Stock
Cytogel Pharma is a bio-pharmaceutical development company that pursues strategic opportunities for pharmaceutical product development.
Sign up today and learn more about Cytogel Pharma Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Cytogel Pharma Stock
Cytogel Pharma (Cytogel) is a bio-pharmaceutical development company founded in 2002 to pursue strategic opportunities for pharmaceutical product development. The company focuses on acquiring promising early-stage programs that offer significant potential both as platform technologies and high value product candidates. Milestone-defined investment of corporate resources permits the company to enhance product value for partnering or licensing, while retaining optimal equity value for our investors. Cytogel is venture backed by Centripetal Capital Partners.
Funding History
| May 2010 | $2.2M |
|---|---|
| March 2014 | $240K |
| January 2015 | $2.7M |
Management
CEO
C. Dean Maglaris
Licensing and Business Development
James J. Hamsher
Chief Scientific Officer/cofounder & Director
Theodore Maione
Press
businesswire - Jan, 4 2016
Research and Markets: Post-Operative Pain - Pipeline Review, Technologies & Forecasts Report H2 2015xconomy - Sep, 29 2015
Vertex Awaits Results of Hepatitis C Drug Trial, Helicos and Pfizer Cut Jobs, St. Jude Acquires LightLab, & More Boston-Area Life Sciences Newsxconomy - Sep, 29 2015
$2.2M for Cytogelxconomy - Sep, 29 2015
Cytogel Pharma Lands $2,200,000 New RoundEquityZen Recognized As:
